牙齿再生市场－全球产业规模、份额、趋势、机会、预测：按类型、最终用户、地区和竞争格局划分，2021-2031年

全球牙齿再生市场预计将从 2025 年的 58.3 亿美元成长到 2031 年的 82.8 亿美元，复合年增长率为 6.02%。

该市场涵盖生物工程疗法，例如干细胞应用和生物活性支架，旨在再生受损牙齿组织并完全取代缺牙。推动市场成长的关键因素包括全球牙周病和牙齿脱落发病率的不断上升，以及日益老化的人口寻求永久性生物修復方案以取代传统植入。例如，为了说明这些疾病带来的巨大经济负担，欧洲牙周病学会估计，到2024年，常见口腔疾病的直接治疗费用将达到每年3,300亿欧元，凸显了开发耐用修復技术的必要性。

另一方面，阻碍市场扩张的一大挑战是开发和商业化这些复杂生物治疗方法的高成本。此外，严格的临床核准监管要求会延缓产品上市，限制病患获得治疗的机会，从而阻碍这些先进再生医学解决方案的快速普及。

市场驱动因素

干细胞疗法和组织工程的进步正在从根本上重塑牙科市场，将牙科治疗从人工替代转向生物修復。研究人员越来越多地利用再生医学，例如抗体药物和干细胞移植，来克服传统植入在恢復牙齿全部活力方面的局限性，促进牙本质、牙髓和珐琅质的自然再生。一项重大进展是，日本Start-UpsTregem BioPharma于2024年6月宣布，将于2024年9月启动一种透过抑制USAG-1蛋白来再生牙齿的新药的人体临床试验。此外，亚利桑那州口腔颚面外科医师协会于2024年6月报告称，一项基于干细胞的牙髓再生临床试验取得了80%的成功率，标誌着该疗法向商业化迈出了重要一步。

随着全球口腔健康负担日益加重，龋齿和牙周疾病的盛行率不断上升，成为市场需求的主要驱动因素。传统的治疗方法，例如根管治疗和牙桥，无法解决生物组织的根本缺失问题，导致老龄化社会中无牙患者数量激增。这使得人们迫切需要再生医学产品，这些产品不仅能够修復损伤，还能逆转损伤。 2024年11月的一篇《牙科新闻》报导凸显了这一问题的严重性，该报道指出，世界卫生组织（WHO）目前估计，全球20岁以上人口中有7%的人完全丧失了牙齿，这强调了开发能够从生物学根源上治疗牙齿缺失的先进再生医学干预措施的紧迫性。

市场挑战

开发和商业化复杂生物治疗方法的高成本是全球牙齿再生市场的主要障碍。这些涉及复杂干细胞应用和生物活性支架的先进疗法需要严格的监管流程和广泛且昂贵的临床试验。因此，製造商被迫设定高价以收回投资，导致许多患者难以负担治疗费用，阻碍了市场渗透。

医疗费用支出本已十分庞大，这进一步加剧了经济障碍。由于患者和保险公司在标准治疗方面已经承担了巨额费用，市场扩张举步维艰，人们也不愿承担昂贵的生物工程替代疗法的额外成本。美国牙医协会 (ADA) 在 2024 年 12 月发布的报告凸显了这种经济压力，报告显示美国年度牙科支出已达 1,740 亿美元。如此巨额的传统治疗方法支出表明，在预算紧张的环境下引入昂贵的新疗法十分困难，这阻碍了再生医学解决方案的广泛商业化。

市场趋势

基于胜肽的治疗趋势正引领牙科治疗领域从机械修復转向模拟天然珐琅质形成的生物活性疗法。这一趋势包括使用自组装胜肽，这些胜肽能够渗透到早期龋损部位，并透过从唾液中吸收钙和磷酸盐，以非侵入性的方式再生牙齿结构。与仅修復受损区域的传统填充物不同，这些仿生材料能够与牙齿的生物基质融合，无需钻牙即可恢復牙齿的完整性。这满足了人们对预防性和微创治疗的需求。该技术的商业性化发展令人瞩目。根据《今日牙科》（Dentistry Today）2025年7月刊报道，自2024年1月以来，美国已有超过42万名患者接受了基于胜肽的牙釉质修復技术治疗，这表明再生医学解决方案正在迅速被临床应用。

同时，3D生物列印技术在客製化支架领域的应用，正透过建构患者特异性的可生物降解基质，革新齿槽骨再生方式。这些列印结构的设计旨在精准贴合患者的解剖缺损部位，提供暂时支撑，促进自然骨再生，最终被人体完全吸收。这避免了金属网片植入后需要进行的二次取出手术。这种个人化方法能够改善复杂重组病例的功能性结果，而传统移植往往难以发挥作用。为了支持这项临床进展，昆士兰大学于2025年1月宣布，研究人员已成功将客製化的3D列印聚己内酯支架应用于另外9名患者的颚骨再生，显示个人化结构再生技术正朝着广泛应用的方向迈进。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球牙齿再生市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（硬组织、软组织）
  • 依最终使用者（牙科诊所、医院等）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美牙齿再生市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲牙科再生市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区牙科再生市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲牙科再生市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲牙科再生市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球牙齿再生市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Institut Straumann AG
• Dentsply Sirona Inc
• 3M Company
• Integra LifeSciences Holdings Corporation
• ZimVie Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Tooth Regeneration Market is projected to expand from USD 5.83 Billion in 2025 to USD 8.28 Billion by 2031, registering a CAGR of 6.02%. This market encompasses bioengineered therapies, such as stem cell applications and bioactive scaffolds, designed to regrow damaged dental tissues or replace missing teeth entirely. Growth is primarily driven by the increasing global incidence of periodontal diseases and tooth loss, alongside an aging population seeking permanent biological alternatives to conventional implants. Highlighting the economic weight of these conditions, the European Federation of Periodontology estimated in 2024 that direct global treatment costs for common oral conditions amount to €330 billion annually, emphasizing the need for durable restorative innovations.

Conversely, a significant challenge hindering market expansion is the high cost associated with developing and commercializing these complex biological therapies. Furthermore, stringent regulatory requirements for clinical approval delay product launches, thereby restricting patient access and limiting the rapid adoption of these advanced regenerative solutions.

Market Driver

Advancements in Stem Cell Therapy and Tissue Engineering are fundamentally reshaping the market by transitioning dental care from synthetic replacements to biological restoration. Researchers are increasingly leveraging regenerative medicine, such as antibody-based drugs and stem cell reimplantation, to stimulate the natural regrowth of dentin, pulp, and enamel, addressing the limitations of traditional implants to restore full vitality. A pivotal development occurred when, according to Harvard Media, Japanese startup Toregem Biopharma announced in June 2024 that human clinical trials would commence in September 2024 for a novel drug designed to regenerate teeth by suppressing the USAG-1 protein. Additionally, Oral & Facial Surgeons of Arizona reported in June 2024 that recent clinical trials achieved an 80% success rate in regenerating dental pulp using stem cells, signaling a major leap toward commercial viability.

The Rising Prevalence of Dental Caries and Periodontal Diseases serves as the primary catalyst for market demand, as the global burden of oral health conditions intensifies. Conventional treatments like root canals and bridges often fail to address the underlying loss of biological tissue, leading to a surge in edentulism among aging populations and creating a critical need for regenerative products that reverse damage rather than merely patching it. Highlighting the severity of this issue, Dental News reported in November 2024 that the World Health Organization estimated 7% of individuals aged 20 and older worldwide now suffer from complete tooth loss, underscoring the urgent necessity for advanced regenerative interventions capable of treating tooth loss at its biological root.

Market Challenge

The high cost associated with developing and commercializing complex biological therapies acts as a primary obstruction to the Global Tooth Regeneration Market. These advanced treatments, which involve intricate stem cell applications and bioactive scaffolds, face stringent regulatory pathways that necessitate extensive and expensive clinical trials. Consequently, manufacturers are forced to set premium price points to recover their investments, thereby rendering these therapies financially out of reach for a significant portion of the patient population and preventing widespread market adoption.

This barrier of affordability is further exacerbated by the immense existing strain on oral healthcare expenditure. The market struggles to scale when patients and insurers are already contending with significant outlays for standard care, making them hesitant to absorb the additional costs of premium bioengineered alternatives. Highlighting this financial pressure, the American Dental Association reported in December 2024 that national dental expenditures in the United States reached $174 billion annually. This substantial spending on conventional treatments underscores the difficulty of introducing expensive new therapies into a budget-constrained environment, thereby stalling the broader commercialization of regenerative solutions.

Market Trends

The Focus on Peptide-Based Therapeutic Modalities is shifting the sector from mechanical repairs to bioactive treatments that mimic natural enamel formation. This trend involves the use of self-assembling peptides that infiltrate early-stage carious lesions, attracting calcium and phosphate from saliva to regenerate tooth structure non-invasively. Unlike traditional fillings which merely patch damage, these biomimetic agents integrate with the tooth's biological matrix to restore integrity without drilling, addressing the demand for preventative and minimally invasive care. Commercial scaling of this technology is evident; according to Dentistry Today in July 2025, more than 420,000 patients in the United States have been treated with peptide-based Curodont technology since January 2024, demonstrating the rapid clinical adoption of these regenerative solutions.

Simultaneously, the Integration of 3D Bioprinting for Custom Scaffolds is transforming alveolar bone regeneration by enabling the fabrication of patient-specific, biodegradable matrices. These printed structures are designed to match the precise anatomical defects of a patient, providing a temporary architecture that supports natural bone regrowth before fully resorbing, which eliminates the need for secondary removal surgeries associated with metallic meshes. This personalized approach enhances functional outcomes in complex reconstructive cases where standard grafts often fail. Validating this clinical progress, the University of Queensland announced in January 2025 that researchers successfully applied custom 3D-printed polycaprolactone scaffolds to regenerate jawbone in a further 9 patients, signaling a move towards widely available personalized structural regeneration.

Key Market Players

• Institut Straumann AG
• Dentsply Sirona Inc
• 3M Company
• Integra LifeSciences Holdings Corporation
• ZimVie Inc.

Report Scope

In this report, the Global Tooth Regeneration Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tooth Regeneration Market, By Type

• Hard Tissue
• Soft Tissue

Tooth Regeneration Market, By End User

• Dental Clinics
• Hospitals
• Others

Tooth Regeneration Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tooth Regeneration Market.

Available Customizations:

Global Tooth Regeneration Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tooth Regeneration Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Hard Tissue, Soft Tissue)
  • 5.2.2. By End User (Dental Clinics, Hospitals, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Tooth Regeneration Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tooth Regeneration Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Tooth Regeneration Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Tooth Regeneration Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Tooth Regeneration Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Tooth Regeneration Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. France Tooth Regeneration Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Tooth Regeneration Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Tooth Regeneration Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Tooth Regeneration Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia Pacific Tooth Regeneration Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Tooth Regeneration Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Tooth Regeneration Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Tooth Regeneration Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Tooth Regeneration Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Tooth Regeneration Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. Middle East & Africa Tooth Regeneration Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Tooth Regeneration Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Tooth Regeneration Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Tooth Regeneration Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. South America Tooth Regeneration Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Tooth Regeneration Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Tooth Regeneration Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Tooth Regeneration Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Tooth Regeneration Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Institut Straumann AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Dentsply Sirona Inc
• 15.3. 3M Company
• 15.4. Integra LifeSciences Holdings Corporation
• 15.5. ZimVie Inc.

16. Strategic Recommendations

17. About Us & Disclaimer